About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Experimental Pathology and Oncology
›
top-articles
Division of Experimental Pathology and Oncology
53
(top 2%)
papers
2.1K
(top 1%)
citations
27
(top 1%)
h
-index
46
(top 1%)
g
-index
54
all documents
2.2K
doc citations
623
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
The Warburg Effect 97 Years after Its Discovery
Cancers
2020
153
2
Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation
Hepatology
2011
108
3
Dual-Specificity Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase–Mediated Control of Growth in Human Hepatocellular Carcinoma
Cancer Research
2008
107
4
Chemoprevention of hepatocarcinogenesis
Alcohol
2002
95
5
SKP2 and CKS1 Promote Degradation of Cell Cycle Regulators and Are Associated With Hepatocellular Carcinoma Prognosis
Gastroenterology
2009
95
6
5′-Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxication
Journal of Hepatology
2001
93
7
Role of HSP90, CDC37, and CRM1 as modulators of P16INK4Aactivity in rat liver carcinogenesis and human liver cancer
Hepatology
2005
87
8
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC
Gut
2009
78
9
Prognostic markers and putative therapeutic targets for hepatocellular carcinoma
Molecular Aspects of Medicine
2010
75
10
Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis
International Journal of Cancer
2007
73
11
Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression
Hepatology
2012
73
12
S
-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers
Hepatology
2012
70
13
Genetic Alterations in Liver Carcinogenesis: Implications for New Preventive and Therapeutic Strategies
Critical Reviews in Oncogenesis
2000
65
14
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis
Hepatology
2002
63
15
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells
Carcinogenesis
2003
59
16
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease
Carcinogenesis
2008
54
17
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53
Hepatology
2011
53
18
Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition
Biochimica Et Biophysica Acta: Reviews on Cancer
2006
49
19
Aurora A Regulates Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APC-Cdc20 Activity
Cancer Research
2009
49
20
Genetic and Epigenetic Control of Molecular Alterations in Hepatocellular Carcinoma
Experimental Biology and Medicine
2009
46
21
Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular Carcinoma
Reviews on Recent Clinical Trials
2007
43
22
Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?
Annals of Translational Medicine
2015
39
23
Ras‐driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control
International Journal of Cancer
2008
38
24
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype
Journal of Hepatology
2011
36
25
S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes
Hepatology
2010
35
26
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible wistar rat strain
1999
34
27
S-Adenosylmethionine Regulates Apurinic/Apyrimidinic Endonuclease 1 Stability: Implication in Hepatocarcinogenesis
Gastroenterology
2009
31
28
An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis
Cellular Oncology (Dordrecht)
2012
30
29
Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma
Medicina (Lithuania)
2019
29
30
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF- B and Mat1A genes in the early stages of rat liver carcinogenesis
Carcinogenesis
2004
28
31
Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison
Biochimica Et Biophysica Acta: Reviews on Cancer
2012
27
32
Polygenic control of hepatocarcinogenesis in Copenhagen × F344 rats
International Journal of Cancer
2004
26
33
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma
Translational Gastroenterology and Hepatology
2018
23
34
Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat
Hepatology
1998
22
35
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease
Oncotarget
2016
20
36
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease
International Journal of Cancer
2010
19
37
Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain
Hepatology
2001
18
38
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting
MAT2A
and
MAT2B
genes
Oncotarget
2019
18
39
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent
Cells
2022
18
40
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis
Cancer Research
2002
17
41
Phenotypic reversion of rat neoplastic liver nodules is under genetic control
International Journal of Cancer
2003
16
42
Genetic control of resistance to hepatocarcinogenesis by the mouseHpcr3locus
Hepatology
2008
16
43
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells
Free Radical Biology and Medicine
2019
13
44
Implication of Bcl-2 family genes in basal and d-amphetamine–induced apoptosis in preneoplastic and neoplastic rat liver lesions
Hepatology
2000
12
45
Mapping a Sex Hormone–Sensitive Gene Determining Female Resistance to Liver Carcinogenesis in a Congenic F344.BN-Hcs4 Rat
Cancer Research
2006
10
46
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/β-catenin pathway and progression of early lesions in the rat
Carcinogenesis
2007
10
47
HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly
Cancers
2021
6
48
Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma
Annals of Translational Medicine
2016
5
49
New insights on the role of epigenetic alterations in hepatocellular carcinoma
Journal of Hepatocellular Carcinoma
2014
4
50
Sulfatase 1: a new Jekyll and Hyde in hepatocellular carcinoma?
Translational Gastroenterology and Hepatology
2016
3
site/software ©
exaly
; All materials licenced under
CC by-SA
.